½ðɳjs93252¼¯ÍÅ-¿ÆÑÐÈËÔ±·¢ÏÖÅÁ½ðÉÈÏÖª¹¦ÄÜÕϰ²¢·¢Ö¢Ô¤²âÊÖ¶Î
2026-03-11 02:09:00
¿ÆÑÐÖ°Ô±·¢Ã÷ÅÁ½ðÉÈÏÖª¹¦Ð§Õϰ²¢·¢Ö¢²Â²âÊÖÍó
ÈÕÆÚ£º2021-10-26 À´Àú£º±¾Õ¾ ¹©¸å£º×ÛºÏÓë¼àÊÓ´¦ ×÷ÕߣºÖÎÀíÔ± ÖÖ±ð£ºÒëÎÄ
ÅÁ½ðɲ¡£¨Parkinson¡¯s disease, PD£©°éÓÐÈÏÖª¹¦Ð§ÕϰµÈ²¢·¢Ö¢£¬¿ÉÊÇÅÁ½ðɲ¡»¼ÕßÖУ¬ÓÐÈÏÖª¹¦Ð§Õϰ²¢·¢Ö¢»¼ÕßµÄÌØÉ«Éв»Ê®·ÖÃ÷È·¡£ ¾ÝÈÕ±¾¿ÆÑ§¼¼ÄÜÕñÐË»ú¹¹£¨JST£©ÍøÕ¾¶¯¾²£¬¾©¶¼ÄêҹѧÑо¿ÍŶӷ¢Ã÷ÅÁ½ðÉÈÏÖª¹¦Ð§Õϰ²¢·¢Ö¢²Â²âÊÖÍó£¬Ñо¿½á¹ûÔÚ½üÈÕµÇÔØÓÚÃÀ¹ú¹ú¼ÊѧÊõÔÓÖ¾¡¶Movement Disorders¡·ÍøÕ¾ÉÏ£¬ÌâΪ£ºLower circulatinglymphocyte count predicts APOE ¦Å4-related cognitive decline inParkinson¡¯sdisease¡£ Ñо¿ÍŶÓÓ¦ÓÃÅÁ½ðɲ¡½øÕ¹±êÖ¾ÎïÑо¿ÏîÄ¿£¨Parkinson's ProgressionMarkers Initiative£¬PPMI£©Êý¾Ý£¬·¢Ã÷Я´øAPOE ¦Å4µÈλ»ùÒòµÄÅÁ½ðɲ¡»¼Õߣ¬ÆäѪҺÖÐÁܰÍϸ°ûÊýÄ¿Ï÷¼õ¿ÉÕýÈ·²Â²â»¼ÕߺóÆÚ»á³ÊÏÖÈÏÖª¹¦Ð§Õϰ£¬¶øÇÒÕâÒ»²Â²â¹¦Ð§½öÏÞÔÚЯ´øAPOE ¦Å4µÈλ»ùÒòµÄÅÁ½ðɲ¡»¼Õߣ¬¶øÎ´Ð¯´øAPOE ¦Å4µÈλ»ùÒòµÄÅÁ½ðɲ¡»¼Õߣ¬ÆäѪҺÖÐÁܰÍϸ°ûÊýÄ¿Ï÷¼õÓëÈÏÖª¹¦½ðɳjs93252¼¯ÍÅ-ЧÕϰÎÞÁªÏµ¹ØÏµÐÔ¡£ ´ËǰÒѾÓÐÑо¿×¢½â£¬ÑªÒºÖÐÁܰÍϸ°ûÊýÄ¿Ï÷¼õԤʾÅÁ½ðɲ¡»¼Õß´æÓÚÄÔÄÚÑ×Ö¢µÄΣº¦¡£»ùÔÚǰÆÚÑо¿½á¹û£¬Ñо¿ÍŶÓÈÏΪÓÚЯ´øAPOE ¦Å4µÈλ»ùÒòµÄÅÁ½ðɲ¡»¼ÕßÖУ¬APOE ¦Å4µÈλ»ùÒòÓëÄÔÄÚÑ×Ö¢¿ÉÄÜÅäºÏ¼¤·¢ÁË»¼ÕßÈÏÖª¹¦Ð§Õϰ¡£ ¸ÃÏîÑо¿ÃþË÷ÁËÅÁ½ðÉÈÏÖª¹¦Ð§Õϰ²¢·¢Ö¢µÄ²Â²âÊÖÍó£¬ÎªÈÏÖª¹¦Ð§Õϰ²¢·¢Ö¢µÄÌáÔç²ÎÓëÒ½ÖÎÌṩÁ˲ο¼¡£ ÔÎÄÁ´½Ó£ºhttps://www.jst.go.jp/pr/announce/20211014/index.html ×¢£º±¾ÎÄÕª±à×ÔÍâÑóÏà¸ÉÑо¿±¨µ¼£¬ÎÄÕÂÄÚÈݲ»´ú±í±¾ÍøÕ¾²»Ñŵ㼰̬¶È£¬½ö¹©²Î¿¼¡£-½ðɳjs93252¼¯ÍÅ-

¸ü¶à²âÊÔÊý¾Ý¾´ÇëÆÚ´ý……
.png)
.jpg)